A
Arctic Bioscience AS
OSE:ABS
Arctic Bioscience AS
OSE:ABS
Price:
3.49
NOK
1.16%
Market Closed
Market Cap:
kr93.7m
Balance Sheet
Balance Sheet Decomposition
Arctic Bioscience AS
Arctic Bioscience AS
Balance Sheet Decomposition is not available for
Arctic Bioscience AS
Arctic Bioscience AS
Balance Sheet
Arctic Bioscience AS
Arctic Bioscience AS
Currency: NOK
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
24
|
11
|
227
|
144
|
80
|
3
|
|
| Cash Equivalents |
24
|
11
|
227
|
144
|
80
|
3
|
|
| Short-Term Investments |
1
|
3
|
3
|
5
|
11
|
11
|
|
| Total Receivables |
12
|
11
|
8
|
13
|
10
|
15
|
|
| Accounts Receivables |
12
|
11
|
8
|
13
|
10
|
15
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
17
|
26
|
29
|
35
|
33
|
29
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
54
|
53
|
267
|
198
|
133
|
58
|
|
| PP&E Net |
3
|
6
|
16
|
22
|
26
|
24
|
|
| PP&E Gross |
0
|
6
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
2
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
25
|
34
|
59
|
107
|
138
|
195
|
|
| Goodwill |
0
|
0
|
0
|
0
|
3
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
3
|
2
|
|
| Total Assets |
82
N/A
|
93
+13%
|
341
+266%
|
328
-4%
|
300
-8%
|
280
-7%
|
|
| Liabilities | |||||||
| Accounts Payable |
6
|
10
|
8
|
18
|
18
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
0
|
0
|
0
|
20
|
|
| Other Current Liabilities |
5
|
11
|
13
|
22
|
21
|
28
|
|
| Total Current Liabilities |
11
|
23
|
21
|
40
|
40
|
68
|
|
| Long-Term Debt |
7
|
7
|
0
|
0
|
2
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
19
N/A
|
29
+58%
|
21
-29%
|
40
+93%
|
42
+3%
|
69
+66%
|
|
| Equity | |||||||
| Common Stock |
1
|
1
|
2
|
2
|
3
|
3
|
|
| Additional Paid In Capital |
63
|
40
|
318
|
285
|
256
|
208
|
|
| Other Equity |
0
|
23
|
0
|
0
|
0
|
0
|
|
| Total Equity |
64
N/A
|
64
+0%
|
321
+401%
|
287
-10%
|
259
-10%
|
211
-18%
|
|
| Total Liabilities & Equity |
82
N/A
|
93
+13%
|
341
+266%
|
328
-4%
|
300
-8%
|
280
-7%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
25
|
25
|
|
Switch to:
Switch to:
See Also
Discover More
